 |
Porfiromycin |
|---|---|
| Trade Name | Promycin |
| Orphan Indication | Squamous cell carcinoma of head and neck |
| USA Market Approval | USA |
| USA Designation Date | 1995-09-19 00:00:00 |
| Sponsor | Boehringer Ingelheim Pharmaceuticals, Inc.;900 Ridgebury Road, PO Box 368;Ridgefield, Connecticut, 06877 |
